MAP3K8 anticorps (AA 256-305)
Aperçu rapide pour MAP3K8 anticorps (AA 256-305) (ABIN2888594)
Antigène
Voir toutes MAP3K8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 256-305
-
Specificité
- COT (Ab-290) Antibody detects endogenous levels of total COT protein.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide from human COT (aa256-305).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
- Approved: IF (1:100 - 1:500), IHC, IHC-P, Peptide-ELISA (1:40000), WB (1:500 - 1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS (without Mg2+, Ca2+), pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- MAP3K8 (Mitogen-Activated Protein Kinase Kinase Kinase 8 (MAP3K8))
-
Autre désignation
- MAP3K8 / TPL2
-
Sujet
-
Name/Gene ID: MAP3K8
Subfamily: MAP3K
Family: Protein Kinase
Synonyms: MAP3K8, C-COT, Cancer Osaka thyroid oncogene, COT, Ewing sarcoma transformant, EST, MEKK8, Proto-oncogene c-Cot, TPL2, Tumor progression locus 2, Protein kinase cot, Tpl-2, ESTF -
ID gène
- 1326
-
UniProt
- P41279
-
Pathways
- Signalisation PI3K-Akt, TCR Signaling
Antigène
-